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e.2013.09Abstract Altered thyroid hormones have been described in patients with diabetes especially those
with poor glycemic control. The aim of this work was to evaluate; the presence of serum anti-thy-
roid peroxidase (serum anti-TPO) autoantibodies and the prevalence of autoimmune thyroid dis-
ease in children with type 1 diabetes mellitus.
Patients and methods: Fifty diabetic children coming for regular follow-up in the diabetes clinic of
El-Shatby University Children’s Hospital were enrolled in the study and 20 healthy children match-
ing in age and sex were taken as control. History taking, clinical examination, measurement of
HbA1c, serum anti-TPO autoantibodies and serum TSH levels were carried out. Serum T4 and
T3 were measured in samples with abnormal serum TSH level.
Results: Serum anti-TPO was positive in 12% of cases, and was negative in 100% of controls.
Serum TSH level was abnormal in 50.0% of positive serum anti-TPO cases, in cases where serum
anti-TPO was negative, 97.7% had normal serum TSH level, this difference was statistically signif-
icant P= 0.004. Good metabolic control was found in 42% of all diabetic children, 19% of them
had positive serum anti-TPO, fair control was seen in 36%, only 5% of them were positive for
serum anti-TPO, 22% had poor control and 9.1% were positive for serum anti-TPO, these differ-
ences had no statistical signiﬁcance P= 0.550.
Conclusion: Although serum TSH screening is more sensitive for detecting thyroid abnormalities in
children and adolescents with type1 diabetes, the presence of positive serum anti-TPO antibodies
may be an earlier marker for thyroid disease, therefore, patients with positive antibodies should
be monitored for serum TSH elevation at yearly intervals.
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.0011. Introduction
Children with type 1 diabetes mellitus (T1DM) are more prone
to develop organ-speciﬁc autoimmune diseases, among which
autoimmune thyroiditis (AIT) is more frequently encountered,
is characterized by the production of autoantibodies against
the thyroid gland, T-lymphocytic inﬁltration of the gland, and
subsequent development of various degrees of thyroidand hosting by Elsevier B.V. All rights reserved.
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thyroid gland proteins, which are thyroglobulin (Tg), a funda-
mental component of thyroid colloid, and thyroid peroxidase
(anti-TPO), an enzyme participating in the production of thy-
roid hormones.1 Reduced serum T3 levels have been observed
in uncontrolled diabetic patients; this ‘‘low serum T3 state’’
could be explained by impairment in peripheral conversion of
serum T4 to serum T3 that normalizes with improvement in gly-
cemic control.2
Hyperthyroidism has long been recognized to promote
hyperglycemia; the half-life of insulin is reduced most likely sec-
ondary to an increased rate of degradation and an enhanced re-
lease of biologically inactive insulin precursors, as for
hypothyroidism, glucose metabolism is affected as well via sev-
eral mechanisms. A reduced rate of liver glucose production is
observed in hypothyroidism and accounts for the decrease in
insulin requirement in hypothyroid diabetic patients. Recurrent
hypoglycemic episodesmay be the presenting signs for the devel-
opment of hypothyroidism in patients with type 1 diabetes.2
American Diabetes Association (ADA) and the Interna-
tional Society for Pediatric and Adolescent Diabetes (ISPAD)
recommend that thyroid antibody tests and thyroid function
should be considered close to the time of diagnosis and
repeated if clinical circumstances suggest the possibility of
thyroid disease, if normal consider rechecking every 1 to
2 years. Subclinical hypothyroidism may be associated with
increased risk of symptomatic hypoglycemia and with reduced
linear growth.3,4 Furthermore, thyroxine replacement therapy
started early in patients with subclinical hypothyroidism
reduces the risk of hyperlipidemia and atherosclerotic heart
disease.5 Hyperthyroidism alters glucose metabolism,
potentially resulting in the deterioration of metabolic control.3
Up till now, there is no consensus about the best policy for
screening for thyroid dysfunction in diabetic children and the
time point of therapeutic intervention.6
The aim of this work was to evaluate; the presence of serum
anti-thyroid peroxidase (serum anti-TPO) autoantibodies and
the prevalence of autoimmune thyroid disease in children with
type 1 diabetes mellitus (DM) attending in Alexandria
University children’s hospital diabetes clinic.Table 1 Distribution of children with T1DM and healthy controls
Cases Controls
No % No %
Age
2–4 3 6.0 3 15.0
5–10 17 34.0 10 50.0
>10 30 60.0 7 35.0
Mean (SD) 10.7 (3.3) 4.8 (3.3)
Sex
Male 19 38.0 10 50.0
Female 31 62.0 10 50.0
Family history of DM
Yes 15 30.0 2 10.0
No 35 70.0 18 90.0
^P value based on Mont Carlo exact probability. FEp: p value for Fishe2. Patients and methods
A cross sectional hospital based study was used to evaluate the
presence of serum anti-TPO antibodies in children and
adolescents with type 1 DM. Fifty diabetic children coming
for follow-up in the diabetes clinic were enrolled in the study
and 20 healthy children matching in age and sex were taken
as control, during the period from October 2011 till May
2012. The inclusion criteria for the diabetic group were: Type
1 DM, age: 1–18 years. The exclusion criteria included:
Subjects with a positive history of previous thyroid disorders,
patient with evident organ system disease e.g. Thalassemia,
congenital heart disease and patients receiving corticosteroids.
All children in the study will be subjected to:
 Detailed history and clinical examination.
 Assessment of anthropometric measures (weight and
height). Anthropometric measurements were expressed as
age and sex speciﬁc standard deviation (SDs) from the
mean (z scores) on the basis of WHO Child Growth
Standards.7
 Measurement of serum anti-TPO Ab: solid-phase, enzyme-
labeled, chemiluminescent sequential immunometric assay.
Normal levels have been deﬁned as less than 35 IU/ml.
 Serum TSH level: solid-phase, chemiluminescent immuno-
metric assay. Reference range: age 1–6 years: 0.85–6.5,
7–12 years: 0.28–4.3, 13–16 years: 0.36–4.7 (uIU/ml/ml).
 Serum T4 and T3 on samples with abnormal serum TSH
level.
 HbA1c was measured by Nyco Card, the mean of the last
four readings for HbA1c was calculated. Reference range:
in diabetic children, values of 6–8.5% represent good met-
abolic control, values of 9–10%, fair control, and values
of >10% or higher represent poor control.8
 Follow-up of serum anti-TPO positive cases was done for
6 months.
 Data were analyzed using the Statistical Package for the
Social Sciences (SPSS 14.0). Differences between the groups
were calculated by the chi-square test for categoricalaccording to age, sex, and family history of DM.
Total X2 P
No %
6 8.6 4.515 0.105
27 38.6
37 52.8
8.9 (4.2) t= 1.93 0.057
29 41.4 0.89 0.357
41 58.6
17 24.3 FEp = 0.122
53 75.7
r Exact test.
Table 2 Serum anti-TPO level in children with T1DM and
healthy controls.
Anti-TPO Cases Controls Total P
No % No % No %
Negative 44 88.0 20 100.0 64 91.4 0.173a
Positive 6 12.0 0 0.0 6 8.6
Total 50 100.0 20 100.0 70 100.0
a P value based on Fisher exact probability.
Table 4 Level of serum anti-TPO and TSH in children with
T1DM.
Anti-TPO Positive Negative Total P
No % No % No %
Normal 3 50.0 43 97.7 46 92.0 0.004
Abnormal 3 50.0 1 2.3 4 8.0
Total 6 100.0 44 100 50 100
!P value based on Fisher exact probability.
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ables, the study protocol was approved by the institutional
review board of the college of medicine in Alexandria Uni-
versity (Egypt), and a written parental consent and child
assent were obtained.3. Results
Table 1 shows that both cases and controls were comparable as
regards age, sex and family history of DM.
Table 2 shows that 12% of cases have positive serum anti-
TPO, and 100% of controls have negative serum anti-TPO,
but this difference was not statistically signiﬁcant P= 0.173.
Table 3 shows that a female predominance was noted in the
cases with positive serum anti-TPO (83.3%). In negative cases,
females were 59.1% but this difference was not statistically sig-
niﬁcant P= 0.387. As regards the duration of DM, height for
age and weight for age, there was no statistical difference be-
tween positive and negative cases P= 0.160, 0.650, 1.000
and 1.000, respectively.Table 3 Serum anti-TPO level, age, sex, duration of DM, and anth
TPO
Negative Positive
No % No
Sex
Male 18 40.9 1
Female 26 59.1 5
Age
2–4 3 6.8 0
5–10 13 29.5 4
>10 28 63.6 2
Duration of DM
<5 years 29 65.9 6
>5 15 34.1 0
Height for age
Normal 40 90.9 6
Stunted 4 9.1 0
Weight for age
Normal 38 86.4 6
Underweight 5 11.4 0
Overweight 1 2.3 0
MCP: P value based on Mont Carlo exact probability.
a P value based on Fisher exact probability *P< 0.05 (signiﬁcant).Table 4 and Fig. 1 illustrate that 50.0% of positive serum
anti-TPO cases had abnormal serum TSH level, in cases where
serum anti-TPO was negative, 97.7% had normal serum TSH
level, this difference was statistically signiﬁcant P= 0.004.
Table 5 and Fig. 2 show that 21 cases (42%) of all diabetic
children had good metabolic control, 19% of them had posi-
tive serum anti-TPO. Fair control was seen in 36%, only 5%
of them were positive for serum anti-TPO. 22% had poor con-
trol, 9.1% were positive for serum anti TPO, these differences
had no statistical signiﬁcance P= 0.550.
Table 6 shows that six cases were serum anti-TPO positive
at initial assessment. Five were females and one was male.
Their age range was 7 to 11 years with a mean of
8.73 ± 2.04. Abnormal serum TSH values were observed in
three cases ‘‘case number 7, 25 and 30’’. Case no 25 had clinical
hypothyroidism evidenced by raised TSH, low serum T4 and
goiter, after 6 months follow-up, case no 7 had subclinical
hypothyroidism evidenced by high serum TSH and normal ser-
um T4, however this case started treatment because of further
rise in serum TSH. Case no 30 had hyperthyroidism evidenced
by low serum TSH and raised serum T4 level.ropometric measurements in children with T1DM.
Total P
% No %
16.7 19 38.0 FEp = 0.387
83.3 31 62.0
0.0 3 6.0 FEp = 0.242
66.7 17 34.0
33.3 30 60.0
100.0 35 70.0 FEp = 0.160
0.0 15 30.0
100.0 46 92.0 FEp = 1.000a
0.0 4 8.0
100.0 44 88.0 MCp= 1.000^
0.0 5 10.0
0.0 1 2.0
Figure 1 Serum anti-TPO and TSH in children with T1DM. Figure 2 Serum anti TPO and control of diabetes.
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Autoimmune diseases affect a substantial percentage of the
population, providing a strong drive for research into ways
whereby such diseases can be detected, prevented and even
cured. It is well known that certain autoimmune diseases occur
in association with each other, such as autoimmune thyroid
disease (ATD), pernicious anemia, celiac disease and idio-
pathic adrenal insufﬁciency, but the most common combina-
tion is type 1 DM and ATD.9
The aim of the present study was directed to evaluate the
presence of serum anti-TPO autoantibodies and the prevalence
of autoimmune thyroid disease in children with type 1 DM.
The prevalence of positive serum anti-TPO antibodies re-
ported among children with T1DM in the present study was
12.0%. Studies done on antimicrosomal antibodies in Brazil-
ian children with type 1 DM reported an average prevalence
of 16.7% as reported by Mantovani et al.,10 meanwhile Euro-
pean whites had a prevalence of 11.1%.11 On the other hand, a
ﬁgure as high as 35% was quoted among American Hispanic
patients12 and 39.6% among Iranian children as reported by
Shariﬁ et al.13 A higher incidence was reported in India
(54.3%). Similarly, the large scale cohort performed by Kord-
onouri et al.14 on type 1 DM patients aged 0.1–20 years
showed an overall prevalence of positive serum anti-TPOTable 6 Clinical and hormonal characteristics of serum anti-TPO p
Case No. Age Sex Anti TOP titer T
7 11.0 F 72.30
25 7.0 F 1001.0ﬁ 2050 7
30 11.0 F 1047.0
33 10.0 F 333.0
44 7.0 F 37.7
50 7.0 M 83.0
Table 5 Serum anti-TPO level in children with T1DM and degree
Serum anti-TPO Good control HbA1c 6–8.5% Fair control HbA
No % No %
Negative 17 34.0 17 34
Positive 4 8.0 1 2
Total 21 42.0 18 36antibodies, as 10%, such ﬁgure is comparable to the preva-
lence reported in the present study, however, studies done on
Arab children with type 1 DM showed different prevalence
ﬁgures than the current study, Mohamed et al.15 in their study
on Sudanese children, reported a lower overall incidence of
6%. A similar ﬁgure was reported by Abdullah et al.16 in Saudi
Arabia which was 8%.
In this study the cut-off value for anti -TPO antibody was
35 IU/ml, Shariﬁ et al.13 using RIA; serum anti-TPO antibod-
ies was set at 16 IU/ml. Moayeri et al.9 and Sarah et al.17 used
ELISA while Kordounori et al.14 used RIA, and the normal
reference range was up to 100 IU/ml. It may be apparent that
the previous studies on the prevalence of thyroid auto-immu-
nity and autoantibodies in children and adolescents with type
1 DM have shown various results depending on the difference
in cut off points, patients’ age, the number of cases, the dura-
tion of diabetes and may be ethnicity of patients studied.
It is well known that organ-speciﬁc endocrine autoimmu-
nity develops more frequently in females, including type 1
DM with thyroid auto-immunity as the production of serum
anti-TPO is inheritable in an autosomal fashion in females
but not in males,15,18 the present study showed that the pres-
ence of positive serum anti-TPO antibodies was more common
among females, with a ratio of 5/1 but no statistical difference
was found. Similarly, Hansen et al.19, Prazny et al.20 and
Shariﬁ et al.13 reported; although female patients with positiveositive cases.
SH TSH follow up T4 Hb A1c
7.70 9.1 3.50ﬁ 4.9 7.80
76.0 1.38 0.10 13.3
2.23 0.031 135 9.00
2.79 3.23 8.9 7.70
2.13 1.7 8.5 6.6
1.74 1.57 7.0 7.20
of diabetes control.
1c 9–10% Poor control HbA1c > 10% Total MCp
No % No %
.0 10 20.0 44 88.0 0.550
.0 1 2.0 6 12.0
.0 11 22.0 50 100.0
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no signiﬁcant difference between both sexes as regards the fre-
quency of positive serum anti-TPO antibodies, on the other
hand, Holl et al.,21 Kordonouri et al.,14 reported that girls were
signiﬁcantly more affected than boys.
The present study reported a signiﬁcant association
between the positivity of serum anti-TPO antibodies and
abnormal serum TSH levels, cases with positive serum anti-
TPO antibodies were more likely to have abnormal serum
TSH. Ghoraishian et al.22 reported strong statistical signiﬁcant
differences between those with normal and raised serum
anti-TPO antibody titers regarding the levels of serum TSH,
Kordonouri et al.14 reported similar ﬁndings where serum
TSH levels were higher in patients with thyroid autoimmunity
than in control subjects and even higher serum TSH levels were
observed in patients with both serum anti-TPO and anti-TG
antibodies. In accordance, Kakleas et al.23 also reported that
the presence of serum anti-thyroid antibodies, including serum
anti-TPO antibodies, was positively associated with serum
TSH levels, along with other factors. The authors reported
that the increase in serum TSH levels was directly proportional
to the degree of anti-thyroid antibody positivity, with the low-
est values occurring in the group without thyroid autoimmu-
nity and the highest ones in the group with double thyroid
antibody positivity.
The elevated serum TSH levels associated with the degree
of anti-thyroid antibody positivity may be due to the direct
involvement of autoantibodies in the pathophysiologic mecha-
nism of thyroid gland destruction or may be due to the associ-
ation of these autoantibodies with tissue destruction by
thyroid-inﬁltrating T cells.23
At initial assessment in the present study we reported differ-
ent types of thyroid dysfunction; 16% of serum anti-TPO po-
sitive cases with clinical hypothyroidism (deﬁned as both a
raised serum TSH and a low free serum T4 level) and 16%
with subclinical hypothyroidism (deﬁned as elevated serum
TSH concentrations with serum free thyroxin (T4) levels with-
in the reference range), furthermore we found, after 6 months
follow-up, one case out of 6 (16% of positive serum anti-TPO
cases) developed hyperthyroidism (deﬁned as a raised free ser-
um T4 with a low serum TSH level). Moayeri et al.9 reported
that serum anti-TPO antibodies were found in 34 (23.4%),
Subclinical hypothyroidism, hypothyroidism and thyrotoxico-
sis occurred in 1, 9, 1 patients, respectively, on the other hand
Mohamed et al.15 found among 6% of anti-TPO positive
cases, 16% of them had biochemical evidence of hypothyroid-
ism, although clinically looked euthyroid, and there was no
evidence of subclinical hypothyroidism or hyperthyroidism.
The present study showed that there was no relationship be-
tween the level of control of diabetes (HbA1c level) and serum
anti-TPO antibody positivity (p= 0.550). The same ﬁnding
was reported by Prazny et al.20 Kakleas et al.23 and Hansen
et al.19
It could be concluded that, although serum TSH screening
is more sensitive for detecting thyroid abnormalities in
children and adolescents with type1 diabetes,24 the presence
of positive serum anti TPO antibodies may be an earlier
marker for thyroid disease, as it is speciﬁc and sensitive;
therefore, patients with positive antibodies should be
monitored for serum TSH elevation at yearly intervals.Conﬂict of interest
None declared.
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